glp-1 receptor agonists and sglt2 inhibitors Blood Pressure-Lowering Effects of https://link.springer.com/article/10.1007/s11906-025-01342-7 Little is known about the
Description
Learn about the Ozempic blindness lawsuit, including NAION and other vision problems, and read about the study linking semaglutide use to severe eye problems.

The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results

Its about infrastructure, reporting, transparency, and accountability

This review article discusses the potential antidepressant effects of GLP-1RAs, especially in the context of their action on the processes related to neuroprotection, inflammation, stress response, energy metabolism, gut-brain crosstalk and the stability of the gut microbiota
